Condition
Ovarian Clear Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Ovarian Clear Cell Carcinoma clinical trials that are recruiting, at sites in 8 countries (most in United States (4), China (1), France (1)). By phase: Phase 1/2 (2), Phase 3 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 8Countries
Newest Ovarian Clear Cell Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Sacituzumab tirumotecan with or without pembrolizumab in ovarian clear cell cancer that has come back or spread | Phase 2 | Boston, Massachusetts | Recruiting | Jul 22, 2026 |
| QL1706 and Bevacizumab as first-line treatment for advanced ovarian clear cell carcinoma | Phase 3 | Wuhan, Hubei | Recruiting | Jun 3, 2025 |
| Combining dostarlimab and LB-100 for treating ovarian clear cell carcinoma | Phase 1/2 | Houston, Texas | Recruiting | Oct 4, 2023 |
| Evaluating Olvi-Vec with chemotherapy for advanced ovarian cancer | Phase 3 | Mobile, Alabama and 32 other locations | Recruiting | Mar 16, 2022 |
| Tulmimetostat treatment for advanced solid tumors and lymphomas | Phase 1/2 | Tampa, Florida and 79 other locations | Recruiting | Sep 26, 2019 |
All recruiting trials (5)
-
Sacituzumab tirumotecan with or without pembrolizumab in ovarian clear cell cancer that has come back or spread
This phase II study tests Sacituzumab tirumotecan alone or with pembrolizumab in adults whose ovarian clear cell cancer has recurred or spread after prior PD-1 therapy.
-
QL1706 and Bevacizumab as first-line treatment for advanced ovarian clear cell carcinoma
This trial tests whether combining QL1706 with bevacizumab can give adults with newly diagnosed advanced ovarian clear cell carcinoma better outcomes than the standard platinum-based chemotherapy.
-
Combining dostarlimab and LB-100 for treating ovarian clear cell carcinoma
This study is testing whether combining two treatments, dostarlimab and LB-100, can help people with recurrent ovarian clear cell carcinoma live longer and feel better.
-
Evaluating Olvi-Vec with chemotherapy for advanced ovarian cancer
This study is testing if a new virus-based treatment called Olvi-Vec, combined with chemotherapy, can help women with tough-to-treat advanced ovarian cancer live longer and feel better.
-
Tulmimetostat treatment for advanced solid tumors and lymphomas
This study is testing a new treatment called Tulmimetostat to see if it can help people with advanced solid tumors and lymphomas feel better and fight their cancer.
Related topics
Quick answers
How many Ovarian Clear Cell Carcinoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (4 trials), China (1 trial), France (1 trial), Italy (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 3: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.